REmote MOniToring usE in Suspected Cases of COVID-19 (Coronavirus): REMOTE-COVID Trial

Imperial College London1 site in 1 country15 target enrollmentJuly 28, 2020

ConditionsCoronavirus

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Coronavirus
Sponsor: Imperial College London
Enrollment: 15
Locations: 1
Primary Endpoint: Deterioration Resulting in Healthcare Review
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The study aims to see if participant deterioration due to suspected coronavirus in a designated location (e.g. hotel) can be identified sooner by wearing the sensor. If sick patients can be identified early, participants are more likely to have better outcomes; the study believes that the sensor can help us do this. The sensor measures heart rate, respiratory rate and temperature every 2 minutes and this can be reviewed by the clinical team looking after the participants.

Registry

clinicaltrials.gov

Start Date

July 28, 2020

End Date

March 26, 2021

Last Updated

last year

Study Type

Observational

Sex

All

Investigators

Sponsor

Imperial College London

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Aged 18 years or over.
•Able to provide written consent.

Exclusion Criteria

•Any participants that withdraw their consent.
•A skin condition/reaction preventing wearing the wearable sensor.
•The presence of a permanent pacemaker or cardiac defibrillator.
•Any form of psychiatric disorder or a condition that, in the opinion of the investigator, may hinder communication with the research team.
•Inability to cooperate or communicate with the research team.